Search

Showing "11155" results for ""

SMART study - treatment breaks lower quality of life

Bacterial vaginosis and illness during pregnancy increase risk of in utero HIV transmission

Protease inhibitor could be used as gel to treat HPV

Final results confirm twice-daily boosted fosamprenavir is comparable to twice-daily Kaletra in treatment-naive

Panacos finds oral fusion inhibitors, provides development update on bevirimat

Draft BHIVA treatment guidelines: respond by Monday September 4th

Many HIV-positive patients in London risking their health by use of alternative therapies

Adenovirus-based HIV vaccines producing strong immune responses

Recombinant forms of HIV emerging rapidly, vaccine designs must keep pace

Swedish prime-boost HIV DNA vaccine shows strong responses

AIDS vaccine could avert up to 27 million infections by 2030

Awareness and use of HIV pre-exposure prophylaxis (PrEP) are found to be low in San Francisco gay and bisexual men

Draft guidelines on prosecuting sexual transmission of HIV, other STIs, in England and Wales now open for public consultation

Safer crack-smoking resources as a viable addition to comprehensive harm reduction programs for reducing HIV and HCV transmission

Is an AIDS vaccine possible? Experts more optimistic after annual vaccine meeting

AIDS vaccine: lack of planning on vectors risks future public health gains

HIV surveillance at immunisation clinics reveals weakness in KwaZulu Natal's PMTCT programme

Immune activation marker, cheap and easy to measure, compares well with CD4 count

Receive the latest HIV research and conference news

Showing "11155" results for ""

SMART study - treatment breaks lower quality of life

Bacterial vaginosis and illness during pregnancy increase risk of in utero HIV transmission

Protease inhibitor could be used as gel to treat HPV

Final results confirm twice-daily boosted fosamprenavir is comparable to twice-daily Kaletra in treatment-naive

Panacos finds oral fusion inhibitors, provides development update on bevirimat

Draft BHIVA treatment guidelines: respond by Monday September 4th

Many HIV-positive patients in London risking their health by use of alternative therapies

Adenovirus-based HIV vaccines producing strong immune responses

Recombinant forms of HIV emerging rapidly, vaccine designs must keep pace

Swedish prime-boost HIV DNA vaccine shows strong responses

AIDS vaccine could avert up to 27 million infections by 2030

Awareness and use of HIV pre-exposure prophylaxis (PrEP) are found to be low in San Francisco gay and bisexual men

Draft guidelines on prosecuting sexual transmission of HIV, other STIs, in England and Wales now open for public consultation

Safer crack-smoking resources as a viable addition to comprehensive harm reduction programs for reducing HIV and HCV transmission

Is an AIDS vaccine possible? Experts more optimistic after annual vaccine meeting

AIDS vaccine: lack of planning on vectors risks future public health gains

HIV surveillance at immunisation clinics reveals weakness in KwaZulu Natal's PMTCT programme

Immune activation marker, cheap and easy to measure, compares well with CD4 count

Receive the latest HIV research and conference news